These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2809191)

  • 21. [A cross-over study of ketanserin compared to placebo, beta-adrenergic blockader, diuretic and alpha 1-adrenergic blockader. Cooperative research in the USSR (the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension). Working Group (4)].
    Metelitsa VI; Filatova NP
    Ter Arkh; 1991; 63(9):91-6. PubMed ID: 1684678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ageing, serotonin and ketanserin.
    Breckenridge A
    Drugs; 1988; 36 Suppl 1():44-54. PubMed ID: 3071462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinico-therapeutic experience with a new antihypertensive drug, ketanserin, in elderly patients].
    Neri G; Iovine C
    Clin Ter; 1989 Sep; 130(5):245-8. PubMed ID: 2530025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term safety and efficacy of ketanserin in essential hypertension: ketanserin versus or in combination with metoprolol.
    Mauersberger H
    J Hypertens Suppl; 1986 Apr; 4(1):S73-5. PubMed ID: 2939217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemodynamic and humoral effects of 2 different doses of ketanserin in aged patients with hypertension].
    Rizzoni D; Castellano M; Beschi M; Agabiti-Rosei E
    Ann Ital Med Int; 1990; 5(4 Pt 2):489-96. PubMed ID: 2102136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of the efficacy of monotherapy with a beta-blocker, a diuretic, and ACE inhibitors in the control of blood pressure during stress].
    Wu SC; Oltrona L; Secchi MB; Mancarella S; Bettazzi L; Civelli M; Sannino C; Loche G; Folli G
    Minerva Cardioangiol; 1989; 37(7-8):323-31. PubMed ID: 2558329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age and 5HT 2-receptor blockade with ketanserin in essential hypertension.
    Bühler FR; Amstein R
    Rev Port Cardiol; 1989 Sep; 8(9):621-4. PubMed ID: 2698721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of ketanserin on arterial pressure at rest and during physical exercise in essential arterial hypertension].
    Gambini G; Gradoli C; Proietti MG; Pinchi G; Fioroni E; Valori C
    Clin Ter; 1989 Jul; 130(2):101-7. PubMed ID: 2529082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ketanserin on blood pressure and biochemical parameters in patients with essential hypertension.
    Wing LM; Chalmers JP; West MJ; Bune AJ; Ayres B; Graham JR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S164-7. PubMed ID: 2412043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years: two international multicentre studies. For the International Study Group.
    Janssens M; Symoens J
    J Hypertens Suppl; 1986 Dec; 4(6):S115-8. PubMed ID: 3302148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of chronic ketanserin therapy on blood pressure and certain humoral and metabolic factors in patients with mild to moderate primary essential hypertension].
    Knypl K; Wocial B; Berent H; Kuçzyńska K; Wasowska T; Brym E; Czerniewska E; Wacławek-Maczkowska J; Januszewicz W
    Pol Arch Med Wewn; 1993 Aug; 90(2):95-104. PubMed ID: 8247951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atenolol and chlorthalidone therapy for hypertension: a double-blind comparison.
    Curry RC; Schwartz KM; Urban PL
    South Med J; 1988 Nov; 81(11):1401-6, 1411. PubMed ID: 3055324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of atherosclerotic complications: controlled trial of ketanserin. Prevention of Atherosclerotic Complications with Ketanserin Trial Group.
    BMJ; 1989 Feb; 298(6671):424-30. PubMed ID: 2495049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter study with ketanserin in essential hypertension: an Argentine experiment.
    Demartini A; Pezzano R; Bernardiner E; Torres J; Genta C; Scheijgrond H; Gypen L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S135-7. PubMed ID: 2446062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin metabolism and age-related effects of antihypertensive therapy with ketanserin.
    Amstein R; Fetkovska N; Ferracin F; Pletscher A; Bühler FR
    Drugs; 1988; 36 Suppl 1():61-6. PubMed ID: 2467792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
    Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension.
    Davis BR; Blaufox MD; Oberman A; Wassertheil-Smoller S; Zimbaldi N; Cutler JA; Kirchner K; Langford HG
    Arch Intern Med; 1993 Aug; 153(15):1773-82. PubMed ID: 8333814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a new antihypertensive agent ketanserin versus methyldopa in the treatment of essential hypertension in older patients: an international multicenter trial.
    Zin C; Copertari P; Landi E; San Martin C; Lopes M; Feruglio F; Alcocer L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S113-8. PubMed ID: 2446057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.